White matter changes in basis pontis in small expansion FMR1 allele carriers with parkinsonism

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 156, Issue 4, 2011, Pages 502-506

  Loesch, D Z ^a,b   Kotschet, K ^c   Trost, N ^c   Greco, C M ^d   Kinsella, G ^a   Slater, H R ^b,e   Venn, A ^f   Horne, M ^c,e  

^a LA TROBE UNIVERSITY   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Fragile X; MRI changes; Parkinson's disease

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; REPETITIVE DNA;

AGED; ALLELE; ARTICLE; BRAIN ATROPHY; BRAIN REGION; CASE REPORT; FRAGILE X SYNDROME; GENE MUTATION; HETEROZYGOTE; HUMAN; IDIOPATHIC DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PONS BASE; PRIORITY JOURNAL; TREMOR; WHITE MATTER;

ADOLESCENT; ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; HETEROZYGOTE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED; PARKINSONIAN DISORDERS; TRINUCLEOTIDE REPEAT EXPANSION; YOUNG ADULT;

EID: 79955114553     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31189     Document Type: Article

References (17)

1. Brunberg JA, Jacquemont S, Hagerman RJ, Berry-Kravis EM, Grigsby J, Leehey MA, Tassone F, Brown WT, Greco CM, Hagerman PJ. 2002. Fragile X premutation carriers: Characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. Am J Neuroradiol 23: 1757-1766.
2. Greco CM, Hagerman RJ, Tassone F, Chudley AE, Del Bigio MR, Jacquemont S, Leehey M, Hagerman PJ. 2002. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125: 1760-1771.
3. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ. 2001. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57: 127-130.
4. Hall DA, Howard K, Hagerman R, Leehey MA. 2009. Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease. Parkinsonism Relat Disord 15: 156-159.
5. Hughes AJ, Daniel SE, Kilford L, Lees AJ. 1992. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184.
6. Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, Berry-Kravis E, Brown WT, Schaeffer S, Kissel J, Tassone F, Hagerman PJ. 2003. Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates. Am J Hum Genet 72: 869-878.
7. Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ. 2004. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291: 460-469.
8. Khaniani MS, Kalitsis P, Burgess T, Slater HR. 2008. An improved diagnostic PCR assay for identification of cryptic heterozygosity for CGG triplet repeat alleles in the fragile X gene (FMR1). Mol Cytogenet 1: 5.
9. Leehey MA. 2009. Fragile X-associated tremor/ataxia syndrome: Clinical phenotype, diagnosis, and treatment. J Investig Med 57: 830-836.
10. Loesch DZ, Churchyard A, Brotchie P, Marot M, Tassone F. 2005. Evidence for, and a spectrum of, neurological involvement in carriers of the fragile X pre-mutation: FXTAS and beyond. Clin Genet 67: 412-417.
11. Loesch DZ, Bui QM, Huggins RM, Mitchell RJ, Hagerman RJ, Tassone F. 2007a. Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats. J Med Genet 44: 200-204.
12. Loesch DZ, Litewka L, Churchyard A, Gould E, Tassone F, Cook M. 2007b. Tremor/ataxia syndrome and fragile X premutation: Diagnostic caveats. J Clin Neurosci 14: 245-248.
13. Loesch DZ, Khaniani MS, Slater HR, Rubio JP, Bui QM, Kotschet K, D'Souza W, Venn A, Kalitsis P, Choo AK, Burgess T, Johnson L, Evans A, Horne M. 2009. Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism. Clin Genet 76: 471-476.
14. Loesch DZ, Godler DE, Evans A, Bui QM, Gehling F, Kotschet KE, Trost N, Storey E, Stimpson P, Kinsella G, Francis D, Thorburn DR, Venn A, Slater HR, Horne M. 2011. Evidence for the toxicity of bidirectional transcripts and mitochondrial dysfunction in blood associated with small CGG expansions in the FMR1 gene in patients with parkinsonism. Genet Med Epub 15 January.
15. Maddalena A, Richards CS, McGinniss MJ, Brothman A, Desnick RJ, Grier RE, Hirsch B, Jacky P, McDowell GA, Popovich B, Watson M, Wolff DJ. 2001. Technical standards and guidelines for fragile X: The first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genet Med 3: 200-205.
16. Morís G, Arias M, López MV, Álvarez V. 2010. Hyperintensity in the basis pontis: Atypical neuroradiological findings in a woman with FXTAS. Move Disord 25: 649-650.
17. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. 2000. Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66: 6-15.